Astrazeneca AZN Earnings Call Transcripts

NYSE AZN
$175.44 -3.33 (-1.86%)
At close: Nov 19, 2026 · 4:00 PM EST
16 earnings calls on file for Astrazeneca, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Astrazeneca Q3 2026 Earnings Call

Oct 30, 2026 15,274 words · 66 min read
  • Joris SilonHead of Investor Relations
  • Pascal SoriotChief Executive Officer
  • Aradhana SarinChief Financial Officer
  • David FredricksonExecutive Vice President, Oncology Business Unit
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Astrazeneca Earnings Call Transcripts

Calls16
LatestOct 30, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2020

Fiscal 2019

All 16 Astrazeneca transcripts Register to get access to Astrazeneca’s earnings call transcripts.

Astrazeneca Earnings Call Transcripts API

Pull Astrazeneca's earnings call transcripts - the full call, prepared remarks and the Q&A, speaker by speaker - into your own models and apps with the Business Quant Transcripts API. Add fyq (e.g. Q2 2025) for a given call. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/transcripts?ticker=AZN&api_key=YOUR_API_KEY